HCW Biologics | DEFA14A: Others
Apr 26 07:43 ET
HCW Biologics | ARS: Annual Report to Security Holders
Apr 26 07:33 ET
HCW Biologics | DEF 14A: Definitive information statements
Apr 26 07:33 ET
HCW Biologics | 10-K: Annual report
Apr 1 16:33 ET
HCW Biologics | 8-K: HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
Apr 1 16:21 ET
HCW Biologics | D: Filing D
Feb 27 16:32 ET
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Wong Hing C
Feb 22 14:27 ET
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Director Greene Rick S.
Feb 22 14:27 ET
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Director Giles Lisa M.
Feb 22 14:27 ET
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Director GARRETT SCOTT T
Feb 22 14:22 ET
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Flowers Lee
Feb 22 14:22 ET
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Byam Rebecca
Feb 22 14:22 ET
HCW Biologics | 8-K: Current report
Feb 22 08:41 ET
HCW Biologics | 8-K: Current report
Jan 12 00:00 ET
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Rhode Peter
Dec 11, 2023 16:56 ET
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Flowers Lee
Dec 11, 2023 16:56 ET
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Rhode Peter
Nov 20, 2023 16:55 ET
HCW Biologics: Q3 2023 Earnings Report
Nov 14, 2023 07:50 ET
HCW Biologics | 8-K: HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
Nov 14, 2023 07:15 ET
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Byam Rebecca
Oct 23, 2023 16:44 ET
No Data
No Data